Professor Michael Valenzuela - Skin2Neuron (S2N) - Alzheimer's Dementia Treatment

Wednesday, 26 October 2022 - 5:00pm to 5:30pm
A man with dark hair stands in front of some x-rays of brains. Brainwaves Logo in blue and purple is below the image in a banner.

Today on our podcast show, Michael, who is one of Australia's most distinguished and multi-award-winning researchers, discusses the latest breakthroughs and treatments for Alzheimer’s dementia.

Professor Michael Valenzuela is co-founder and CEO of Skin2Neuron (S2N), a creative biotech company for the treatment and prevention of Alzheimer’s dementia.

S2N’s regenerative medicine technology is based on a discovery by Michael and his team at the University of Sydney in 2019. They found that there was a remarkable degree of shared biology between stem cells in the brain and stem cells in skin.


Wednesday 5:00pm to 5:30pm
Challenging the mainstream, negative stereotypes of people with a mental illness ths program actively engages those living with a mental illness as researchers, interviewers, performers and program designers while promoting community mental health awareness.


Members of Wellways Australia